GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for udp-N- acetylenolpyruvoylglucosamine reductase (B1LAW8)

Analyse AlphaFold monomer V2.0 prediction for udp-N- acetylenolpyruvoylglucosamine… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
B1LAW8
Type
protein
Length
300 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x9e5E98E011361C5888c92e2CDb7652E02Bd5C7Ed
Molecule
Udp-N-acetylenolpyruvoylglucosamine reductase
UniProt
B1LAW8
Pockets
1 · best druggability 0.78

Structure

1 distinct chain · 33% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUdp-N-acetylenolpyruvoylglucosamine reductaseprotein30033% helix, 32% strandB1LAW8

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17370.780.8282empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.